Related Experiment Video
Updated: Jul 6, 2026

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
Published on: February 2, 2024
Structural insight into the function of myelin basic protein as a ligand for integrin alpha M beta 2
Romualdas Stapulionis1, Cristiano Luis Pinto Oliveira, Mikkel Carstensen Gjelstrup
1Biophysical Immunology Laboratory, University of Aarhus, Aarhus, Denmark.
Multiple sclerosis involves immune cells destroying myelin. This study shows myelin basic protein (MBP) binds to integrin alpha(M)beta(2), a mechanism potentially targeted by glatiramer acetate to treat MS.
Area of Science:
- Neuroimmunology
- Cellular and Molecular Biology
Background:
- Multiple sclerosis (MS) is an inflammatory disease characterized by immune cell infiltration and myelin sheath destruction in nerve tissue.
- The precise mechanism by which phagocytic cells recognize myelin in MS remains largely unknown.
- Myelin basic protein (MBP) is a key autoantigen implicated in MS pathogenesis.
Purpose of the Study:
- To investigate the interaction between myelin components and phagocytic cell receptors.
- To elucidate the role of integrin alpha(M)beta(2) in myelin recognition during MS.
- To explore the mechanism of action for glatiramer acetate in MS treatment.
Main Methods:
- Investigated MBP as a ligand for integrin alpha(M)beta(2) (Mac-1, CD11b/CD18) on phagocytic cells.
- Analyzed conformational changes of MBP when released from the myelin sheath.
- Assessed the interaction of glatiramer acetate with unfolded MBP and its effect on MBP-integrin binding.
Main Results:
- Myelin basic protein (MBP) was identified as a potent and specific ligand for integrin alpha(M)beta(2).
- MBP exhibits significant conformational changes upon liberation from the myelin sheath.
- Glatiramer acetate was found to mimic labile regions of MBP, bind to alpha(M)beta(2) in an unfolded state, and inhibit MBP binding.
Conclusions:
- A direct link between MBP, glatiramer acetate, and the alpha(M)beta(2) integrin in MS pathogenesis is established.
- A novel model for MS pathogenesis is proposed, involving the recognition of unfolded MBP by the alpha(M)beta(2) integrin.
- This finding offers new insights into the therapeutic mechanisms of glatiramer acetate for multiple sclerosis.
Related Concept Videos
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Some...
Anchoring Junctions
Laminins are the Adhesive Proteins of Basal Lamina
In humans, the five forms of alpha chains are LAMA 1, LAMA 2, LAMA 3, LAMA 4, and LAMA 5. The four forms of beta chains are LAMB 1, LAMB 2, LAMB 3, and LAMB 4. The three forms of gamma...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...

